OrPro Therapeutics' Unattributed Round

OrPro Therapeutics raised a round of funding on December 18, 2013.

OrPro Therapeutics is a pre-clinical stage biopharmaceutical company developing a class of safe, well-tolerated and effective inhaled non-systemic drugs based on the thioredoxin active site for the tr…

Articles about OrPro Therapeutics' Unattributed Round: